Overview
Status
Active
Registry date
2011-06-03
Share capital
5 000,00 PLN
Registered address
Drzymały 3A, 75-074 Koszalin, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 61 days for 2021).
- 202508/07/2026
- 202407/07/2025
- 202316/07/2024
- 202217/07/2023
- 202114/09/2022
- 202011/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 645.82kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -33.37kMedianUSD 20.66kAverageUSD 86.53k
Operating costs
This companyUSD 675.84kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 210.70kMedianUSD 545.50kAverageUSD 1.76m
Industry
Authorized Representatives
Kazimierz Szczepan Ligarski – President of the Management Board
Lidia Ligarska – Vice President of the Management Board
Manner of representation
One-person representation.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Lidia Ligarskaage 64 | 50 | $675.31 | 50% |
Kazimierz Szczepan Ligarskiage 64 | 50 | $675.31 | 50% |
Kazimierz Szczepan Ligarski and Lidia Ligarska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-11-15.
95 2030 0045 1110 0000 0217 5560
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $31,188.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,534$2,534 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,964$2,964 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,868$2,868 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| Pharmer Polskasp. z o.o. | $15,884.06 | punktapteczny.online | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-10-22 | PKD change (Removed: 21.20.Z, 68.20.Z, 68.32.Z, 70.22.Z, 73.11.Z) | |
| 2011-06-03 | Entered in the register |
FAQ
The main business activity of Aptecom focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on June 3, 2011.
The headquarters is located at: Drzymały 3A, 75-074 Koszalin.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $622,763, representing an increase of 3.7% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $23,433, meaning the company decreased its profit by 4.9%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $413,726 in 2024, representing 70% of all operating expenses.
Last updated: 2026-07-15